[Association between serum adiponectin and mean blood pressure].
Xinli Li, Min Tong, Qiong Xu, Xin-zheng Lu, Zhenzhen Wang, Yanli Zhou, Haifeng Zhang, Kejiang Cao, Jun Huang
Abstract
Xinli Li, Min Tong, Qiong Xu, Xin-zheng Lu, Zhenzhen Wang, Yanli Zhou, Haifeng Zhang, Kejiang Cao, Jun Huang
Abstract
OBJECTIVE: To investigate the relationship between serum adiponectin and mean blood pressure (BP). METHODS: A total of 187 subjects were divided into four groups according to BP levels: optimal blood pressure group (n = 38), high normal blood pressure group (n = 50), treated hypertension group (n = 54) and untreated hypertension group (n = 45). Serum adiponectin and microalbuminuria were detected by radioimmunology assay. Insulin resistant index defined as HOMA-IR and urinary concentration of microalbuminuria/urinary concentration of creatinine defined as albumin creatinine ratio (ACR) were calculated. RESULTS: (1) Serum adiponectin decreased in proportion to BP increase and the serum adiponectin level was significantly higher in treated hypertension group than untreated hypertension group. (2) Correlation analysis showed that adiponectin concentration was negatively correlated with mean blood pressure (P < 0.01). (3) Multivariate regression analysis revealed that mean blood pressure and HOMA-IR were independent predictors of serum adiponectin level. CONCLUSIONS: Mean blood pressure was the main determinant of serum adiponectin level and negatively correlated to serum adiponectin level.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the relationship between serum adiponectin and mean blood pressure (BP). METHODS: A total of 187 subjects were divided into four groups according to BP levels: optimal blood pressure group (n = 38), high normal blood pressure group (n = 50), treated hypertension group (n = 54) and untreated hypertension group (n = 45). Serum adiponectin and microalbuminuria were detected by radioimmunology assay. Insulin resistant index defined as HOMA-IR and urinary concentration of microalbuminuria/urinary concentration of creatinine defined as albumin creatinine ratio (ACR) were calculated. RESULTS: (1) Serum adiponectin decreased in proportion to BP increase and the serum adiponectin level was significantly higher in treated hypertension group than untreated hypertension group. (2) Correlation analysis showed that adiponectin concentration was negatively correlated with mean blood pressure (P < 0.01). (3) Multivariate regression analysis revealed that mean blood pressure and HOMA-IR were independent predictors of serum adiponectin level. CONCLUSIONS: Mean blood pressure was the main determinant of serum adiponectin level and negatively correlated to serum adiponectin level.
Key concepts: Adiponectin, Microalbuminuria, Medicine, Blood pressure, Internal medicine, Creatinine, Endocrinology, Mean blood pressure